Literature DB >> 31848873

TAAR Agonists.

Zhengrong Xu1,2,3, Qian Li4,5.   

Abstract

Trace amine-associated receptors (TAARs) are a family of G protein-coupled receptors (GPCRs) that are evolutionarily conserved in vertebrates. The first discovered TAAR1 is mainly expressed in the brain, and is able to detect low abundant trace amines. TAAR1 is also activated by several synthetic compounds and psychostimulant drugs like amphetamine. Activation of TAAR1 by specific agonists can regulate the classical monoaminergic systems in the brain. Further studies have revealed that other TAAR family members are highly expressed in the olfactory system which are termed olfactory TAARs. In vertebrates, olfactory TAARs can specifically recognize volatile or water-soluble amines. Some of these TAAR agonists are produced by decarboxylation of amino acids. In addition, some TAAR agonists are ethological odors that mediate animal innate behaviors. In this study, we provide a comprehensive review of TAAR agonists, including their structures, biosynthesis pathways, and functions.

Entities:  

Keywords:  Agonist; G protein-coupled receptor (GPCR); Olfactory receptor; Trace amine-associated receptor (TAAR); Trace amines; Volatile amines

Mesh:

Substances:

Year:  2019        PMID: 31848873     DOI: 10.1007/s10571-019-00774-5

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  125 in total

1.  3-iodothyronamine differentially modulates α-2A-adrenergic receptor-mediated signaling.

Authors:  Juliane Dinter; Jessica Mühlhaus; Simon Friedrich Jacobi; Carolin Leonie Wienchol; Maxi Cöster; Jaroslawna Meister; Carolin Stephanie Hoefig; Anne Müller; Josef Köhrle; Annette Grüters; Heiko Krude; Jens Mittag; Torsten Schöneberg; Gunnar Kleinau; Heike Biebermann
Journal:  J Mol Endocrinol       Date:  2015-04-15       Impact factor: 5.098

2.  Evidence for extrathyroidal formation of 3-iodothyronamine in humans as provided by a novel monoclonal antibody-based chemiluminescent serum immunoassay.

Authors:  Carolin S Hoefig; Josef Köhrle; Georg Brabant; Kashinath Dixit; Beng Yap; Christian J Strasburger; Zida Wu
Journal:  J Clin Endocrinol Metab       Date:  2011-04-13       Impact factor: 5.958

3.  High-affinity olfactory receptor for the death-associated odor cadaverine.

Authors:  Ashiq Hussain; Luis R Saraiva; David M Ferrero; Gaurav Ahuja; Venkatesh S Krishna; Stephen D Liberles; Sigrun I Korsching
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

4.  Investigations of valanimycin biosynthesis: elucidation of the role of seryl-tRNA.

Authors:  Ram P Garg; Xuelei L Qian; Lawrence B Alemany; Sean Moran; Ronald J Parry
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-01       Impact factor: 11.205

5.  In Vitro Characterization of Psychoactive Substances at Rat, Mouse, and Human Trace Amine-Associated Receptor 1.

Authors:  Linda D Simmler; Danièle Buchy; Sylvie Chaboz; Marius C Hoener; Matthias E Liechti
Journal:  J Pharmacol Exp Ther       Date:  2016-01-20       Impact factor: 4.030

6.  Expression of neuronal trace amine-associated receptor (Taar) mRNAs in leukocytes.

Authors:  Daniel A Nelson; Melanie D Tolbert; Sam J Singh; Kenneth L Bost
Journal:  J Neuroimmunol       Date:  2007-09-27       Impact factor: 3.478

7.  Functional evaluation of the receptors mediating vasoconstriction of rat aorta by trace amines and amphetamines.

Authors:  Kenneth J Broadley; Martina Fehler; William R Ford; Emma J Kidd
Journal:  Eur J Pharmacol       Date:  2013-05-09       Impact factor: 4.432

8.  Non-redundant coding of aversive odours in the main olfactory pathway.

Authors:  Adam Dewan; Rodrigo Pacifico; Ross Zhan; Dmitry Rinberg; Thomas Bozza
Journal:  Nature       Date:  2013-04-28       Impact factor: 49.962

Review 9.  Update on 3-iodothyronamine and its neurological and metabolic actions.

Authors:  Riccardo Zucchi; Alice Accorroni; Grazia Chiellini
Journal:  Front Physiol       Date:  2014-10-16       Impact factor: 4.566

10.  Molecular Evolution and Functional Divergence of Trace Amine-Associated Receptors.

Authors:  Seong-Il Eyun; Hideaki Moriyama; Federico G Hoffmann; Etsuko N Moriyama
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

View more
  7 in total

Review 1.  Trace Amines and Trace Amine-Associated Receptors: A New Frontier in Cell Signaling.

Authors:  Zachary Freyberg; Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2020-01-31       Impact factor: 5.046

2.  Expression of Trace Amine-Associated Receptors in the Murine and Human Hippocampus Based on Public Transcriptomic Data.

Authors:  Nataliia V Katolikova; Anastasia N Vaganova; Evgeniya V Efimova; Raul R Gainetdinov
Journal:  Cells       Date:  2022-06-01       Impact factor: 7.666

Review 3.  Olfactory signaling via trace amine-associated receptors.

Authors:  Adam Dewan
Journal:  Cell Tissue Res       Date:  2020-11-25       Impact factor: 5.249

4.  Two entry tunnels in mouse TAAR9 suggest the possibility of multi-entry tunnels in olfactory receptors.

Authors:  ZhengRong Xu; LingNa Guo; XiaoYun Qian; ChenJie Yu; ShengJu Li; ChengWen Zhu; XiaoFeng Ma; Hui Li; GuangJie Zhu; Han Zhou; WenXuan Dai; Qian Li; Xia Gao
Journal:  Sci Rep       Date:  2022-02-17       Impact factor: 4.379

5.  Evolution of Brain-Expressed Biogenic Amine Receptors into Olfactory Trace Amine-Associated Receptors.

Authors:  Lingna Guo; Wenxuan Dai; Zhengrong Xu; Qiaoyi Liang; Eliot T Miller; Shengju Li; Xia Gao; Maude W Baldwin; Renjie Chai; Qian Li
Journal:  Mol Biol Evol       Date:  2022-03-02       Impact factor: 16.240

6.  Coordination of two enhancers drives expression of olfactory trace amine-associated receptors.

Authors:  Aimei Fei; Wanqing Wu; Longzhi Tan; Cheng Tang; Zhengrong Xu; Xiaona Huo; Hongqiang Bao; Yalei Kong; Mark Johnson; Griffin Hartmann; Mustafa Talay; Cheng Yang; Clemens Riegler; Kristian J Herrera; Florian Engert; X Sunney Xie; Gilad Barnea; Stephen D Liberles; Hui Yang; Qian Li
Journal:  Nat Commun       Date:  2021-06-18       Impact factor: 14.919

7.  Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia.

Authors:  Michele L R Heffernan; Lee W Herman; Scott Brown; Philip G Jones; Liming Shao; Michael C Hewitt; John E Campbell; Nina Dedic; Seth C Hopkins; Kenneth S Koblan; Linghong Xie
Journal:  ACS Med Chem Lett       Date:  2021-12-06       Impact factor: 4.345

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.